These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Serum tartrate-resistant acid phosphatase 5b, but not 5a, correlates with other markers of bone turnover and bone mineral density. Halleen JM; Ylipahkala H; Alatalo SL; Janckila AJ; Heikkinen JE; Suominen H; Cheng S; Väänänen HK Calcif Tissue Int; 2002 Jul; 71(1):20-5. PubMed ID: 12073156 [TBL] [Abstract][Full Text] [Related]
9. [Development for the determination of band 5b tartrate-resistant acid phosphatase activity in serum]. Uchida K; Nakanishi M; Yoh K Rinsho Byori; 2001 Jan; 49(1):51-5. PubMed ID: 11215484 [TBL] [Abstract][Full Text] [Related]
10. Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption. Halleen JM; Tiitinen SL; Ylipahkala H; Fagerlund KM; Väänänen HK Clin Lab; 2006; 52(9-10):499-509. PubMed ID: 17078477 [TBL] [Abstract][Full Text] [Related]
11. Specificity and clinical performance of two commercial TRACP 5b immunoassays. Ylipahkala H; Fagerlund KM; Janckila AJ; Houston B; Laurie D; Halleen JM Clin Lab; 2009; 55(5-6):223-8. PubMed ID: 19728556 [TBL] [Abstract][Full Text] [Related]
12. Tartrate-resistant acid phosphatase 5b is a potential biomarker for rheumatoid arthritis: a pilot study in Han Chinese. Cheng T; Wang M; Chen Z; Eisenberg RA; Zhang Y; Zou Y; Deng Y; Wang M; Zhou L Chin Med J (Engl); 2014; 127(16):2894-9. PubMed ID: 25131223 [TBL] [Abstract][Full Text] [Related]
14. Development of a kinetic assay for band 5b tartrate-resistant acid phosphatase activity in serum. Nakanishi M; Yoh K; Miura T; Ohasi T; Rai SK; Uchida K Clin Chem; 2000 Apr; 46(4):469-73. PubMed ID: 10759470 [TBL] [Abstract][Full Text] [Related]
15. Clinical performance of six different serum tartrate-resistant acid phosphatase assays for monitoring alendronate treatment. Fagerlund KM; Janckila AJ; Ylipahkala H; Tiitinen SL; Nenonen A; Cheng S; Uusi-Rasi K; Yam LT; Väänänen HK; Halleen JM Clin Lab; 2008; 54(9-10):347-54. PubMed ID: 19097492 [TBL] [Abstract][Full Text] [Related]
16. Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption. Hannon RA; Clowes JA; Eagleton AC; Al Hadari A; Eastell R; Blumsohn A Bone; 2004 Jan; 34(1):187-94. PubMed ID: 14751577 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the activity of tartrate-resistant acid phosphatase isoform 5b in normal Chinese children--a novel marker for bone growth. Chen CJ; Chao TY; Janckila AJ; Cheng SN; Ku CH; Chu DM J Pediatr Endocrinol Metab; 2005 Jan; 18(1):55-62. PubMed ID: 15679069 [TBL] [Abstract][Full Text] [Related]
18. Development of a novel fragments absorbed immunocapture enzyme assay system for tartrate-resistant acid phosphatase 5b. Ohashi T; Igarashi Y; Mochizuki Y; Miura T; Inaba N; Katayama K; Tomonaga T; Nomura F Clin Chim Acta; 2007 Feb; 376(1-2):205-12. PubMed ID: 17045980 [TBL] [Abstract][Full Text] [Related]
19. Electrophoretic study of tartrate-resistant acid phosphatase isoforms in endstage renal disease and rheumatoid arthritis. Takahashi K; Janckila AJ; Sun SZ; Lederer ED; Ray PC; Yam LT Clin Chim Acta; 2000 Nov; 301(1-2):147-58. PubMed ID: 11020469 [TBL] [Abstract][Full Text] [Related]
20. A novel immunoassay for the determination of tartrate-resistant acid phosphatase 5b from rat serum. Alatalo SL; Peng Z; Janckila AJ; Kaija H; Vihko P; Vaananen HK; Halleen JM J Bone Miner Res; 2003 Jan; 18(1):134-9. PubMed ID: 12510815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]